Apr 21, 2020
Hoth Therapeutics Announces Top Line Preclinical Data from Cutaneous Lupus Erythematosus (CLE) Study
Apr 15, 2020
FDA Grants Fast Track Designation to RemeGen's Telitacicept as a Treatment for Systemic Lupus Erythematosus
Apr 14, 2020
Research Among People Living With Lupus Finds Widespread, Under-Addressed Anxiety and Depression
Apr 09, 2020
Hydroxychloroquine, Lupus and COVID-19: What We've Learned and What's Next?
Apr 07, 2020
Lupus Therapeutics, Affiliate Of Lupus Research Alliance, Developing A Study Focused On Lupus Patients And COVID-19
Jan 17, 2020
AMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco
Dec 19, 2019
Greater Flexibility in Clinical Trial Design Needed for Lupus
Dec 18, 2019
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
Nov 15, 2019
RemeGen, Ltd. Announces Positive Results from Phase IIb Clinical Trial in Systemic Lupus Erythematosus
Nov 11, 2019
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
Oct 24, 2019
Lupus Research Alliance Announces 2019 Distinguished Innovator Awards Aimed at New Lupus Treatments
Sep 09, 2019
The Life Sciences Division Update Report on ImmuPharma plc Post AstraZeneca plc Announcement of Anifrolumab Successfully Navigating a Second Phase III Clinical Trial in Lupus
Aug 29, 2019
Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial
Aug 08, 2019
Provention Bio Initiates Phase 1b/2a PREVAIL Clinical Trial Evaluating PRV-3279 in Lupus
Jun 27, 2019
Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus
Jun 13, 2019
VALUE Study Results Show Custom Mobile App Lets Patients Accurately Report Response to Treatment
May 29, 2019
New Study Partly Funded by the Lupus Research Alliance Reveals Novel Lupus Drug Targets
May 29, 2019
Lupus LA Launches Powerful Campaign Promoting Community in the Fight to Cure Lupus
May 20, 2019
Lupus Treatments Can Be Tailored to Patient's Individual Cells, Study Shows
May 14, 2019
Hoth Therapeutics Signs Term Sheet with Zylö Therapeutics to Acquire a License and Jointly Develop a Product to Treat Lupus